ArticleCancers2022

A Novel High-Throughput Screening Method for a Human Multicentric Osteosarcoma-Specific Antibody and Biomarker Using a Phage Display-Derived Monoclonal Antibody.

Takuma Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.